Find and Pitch Jounalists, Get Your Story Covered

Tags: adjuvants, biochemistry, bioengineering, immune response, immunology, vaccine design, yeast alectinib lung cancer adjuvant chemotherapy

	Profile	Recent Articles on Subject
1	Angus Chen STAT News Undignified, unfunny journalist. Health, cancer coverage at STAT News. journalismhealthcancer researchSTAT News	STAT+: Johnson & Johnson says its lung cancer drug significantly extended survival - 25 days ago
2	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Avutometinib Plus Defactinib Moves One Step Closer to Approval for Treatment of Ovarian Cancer - 25 days ago SABCS 2024: Using Tumor Immune Profiles to Guide Neoadjuvant Therapy in Young Breast Cancer Patients - about 2 months ago Study: Blended Antioxidant Supplement Could Improve Age-Related Health Decline - 10 months ago Adjuvanted RSVPreF3 Vaccine Could Prevent RSV Infection Among Older Adults - 10 months ago
3	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Sequencing in Advanced Urothelial Carcinoma - 3 months ago 'Very Clear Signal' That Survival Improved With Addition of Durvalumab in SCLC - 7 months ago Daratumumab Added to Standard Therapy Improves PFS in Multiple Myeloma - about 1 year ago Dato-DXd More Effective, Tolerable Than Chemo for Metastatic Breast Cancer - about 1 year ago 'Exploding' Field of Antibody-Drug Conjugates Makes Inroads in Ovarian Cancer - about 1 year ago Tralokinumab Controls Moderate-to-Severe AD Over the Long Term - about 1 year ago The Exciting Potential of Antibody-Drug Conjugates in Lung Cancer - over 1 year ago
4	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Neoadjuvant Pembrolizumab Plus Chemotherapy Followed by Adjuvant Pembrolizumab Is New Standard of Care for High-Risk Early-Stage TNBC - 5 months ago Advances in the Treatment of Resectable NSCLC: Key Insights From CheckMate 77T, NEOSTAR, and CA209-159 Trials - 5 months ago Managing Adverse Event Profiles for Three Bispecific Antibodies Approved for Lymphoma - 10 months ago
5	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	Retifanlimab-Chemo Combo Boosts PFS in Advanced Squamous Cell Anal Cancer - 5 months ago A Blenrep Comeback? Cancer Vaccine for Dogs; U.K. Snubs Enhertu - 11 months ago Perioperative Tislelizumab Demonstrates Survival Benefit in NSCLC - 12 months ago De-Escalating Breast Cancer Treatment Feasible After Response to Neoadjuvant Chemo - about 1 year ago First Treatment Approved for Genetic Clotting Disorder - about 1 year ago Neoadjuvant Cemiplimab Shows Potential as an Option for Cutaneous SCC - over 1 year ago Antibody-Drug Conjugate Improves PFS in Pretreated Breast, Lung Cancers - over 1 year ago Multi-Agent Treatment Offers Hope in Advanced or Recurrent Endometrial Cancer - over 1 year ago
6	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Approves Amivantamab-Vmjw and Lazertinib for First-Line Treatment of NSCLC - 5 months ago FDA Approves V116 for Prevention of Invasive Pneumococcal Disease and Pneumonia - 8 months ago FDA Accepts Supplemental New Drug Application for Adagrasib for Colorectal Cancer - 11 months ago Neoadjuvant Chemotherapy Could Help Patients With Breast Cancer Skip Regional Nodal Irradiation - about 1 year ago Experimental Pneumococcal Vaccine Successfully Prevents Disease in Animal Models - about 1 year ago FDA Approves Enfortumab Vedotin, Pembrolizumab for Treatment of Urothelial Cancer - about 1 year ago Study: Preventative Drug Lists Improve Affordability, Adherence to Asthma Medication - about 1 year ago
7	Amy Baxter Pharma Voice Scientist, inventor, former pediatrician. Atlanta, Georgia pain relieftechnologyinnovation	A potential MS ‘game changer’ could bring more safety to the table — even against viruses - 6 months ago
8	Meagan Parrish Pharma Voice Senior editor @industrydive. Pharma world follower. Wisconsin, USA pharmaceuticalsjournalismparenting	Up-and-comers look for an edge in the bustling ADC field - 7 months ago
9	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	AstraZeneca, Daiichi Sankyo Drug Enhertu Becomes First Tumor-Agnostic ADC Cancer Med - 10 months ago
10	Shannon Firth MedPage Today Washington correspondent for MedPageToday. CUNYJschool pride. Healthcarejournalism	Experts in Industry Wrangle Over Whether Combo Vaccines Are Beneficial for Adults - 10 months ago

Journalists covering adjuvant